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Abstract
Background: Lung cancer rarely metastasizes to the breast, and breast metastasis of pulmonary pleomorphic
carcinoma has not been previously reported.
Case presentation: The patient was a 66-year-old woman who became aware of a mass in the right breast and
visited a physician. She was referred to our department for close examination, upon which she was diagnosed with
double cancer (right breast cancer and left lung cancer). Needle biopsy findings for the mammary tumor were
similar to those for the lung biopsy specimen, but spindle cell or metaplastic carcinoma were possibilities. The
initial diagnosis was primary breast cancer. Left upper lobectomy and lymph node dissection were performed for
left lung cancer. Both the lung and mammary tumors grew rapidly during the wait for surgery. The white
blood cell count was within the normal range at the first examination, but was markedly increased and
remained at a high level after surgery for lung cancer. Preoperative chemotherapy was initially planned for
the mammary tumor, but surgical treatment was selected in consideration of the clinical course, and right
mastectomy and full thickness skin graft were performed. However, the disease rapidly aggravated and the
patient died 5 months after the first examination.
Conclusion: The final diagnosis was pulmonary pleomorphic carcinoma with metastasis to the breast on
postoperative histopathological examination. We describe this case as the first reported example of breast
metastasis of pulmonary pleomorphic carcinoma.
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Background
Lung primary pleomorphic carcinoma is a relatively
rare tumor that accounts for about 0.3% of all lung can-
cer cases and has a poor prognosis [1]. Lung cancer
metastasizes to distant regions such as the liver and
brain, but rarely metastasizes to the breast. We encoun-
tered a patient who was diagnosed with double cancer
(breast and lung cancers) before surgery. Left upper
lobectomy and right mastectomy were performed, and
the lesions were subsequently histopathologically diag-
nosed as pulmonary pleomorphic carcinoma with me-
tastasis to the breast. We report this unique case with a
literature review.
Case presentation
The patient was a 66-year-old woman with a chief com-
plaint of a mass in the right breast. She had become
aware of the mass and visited a physician. A lung tumor
was noted on CT, and the patient was referred to our
department for suspected double cancer (lung and
breast cancers). The patient was diagnosed with double
cancer (right breast and left lung cancers) on close
examination. Her medical history was unremarkable, but
she had smoked 20 cigarettes/day from age 20 to 64 years
old. Her first menstruation was at 13 years old and
52 years old at menopause. She had two deliveries. She
had no relevant family medical history.
A hard mass of 2 cm in size was palpated in the B
region of the right breast. The mass was mobile. The
surface was relatively smooth, and the boundary was
relatively unclear. The axillary and supraclavicular lymph
nodes were not palpable. Blood counts and biochemistry
findings were within normal ranges. CEA was high
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(9.3 ng/mL), but CA15-3, proGRP, and CYFRA were
within their normal ranges. Serum G-CSF was as high as
84.0 pg/mL (standard value ≤39.0 pg/mL).
Mammography showed a shadow of an intense ir-
regular mass in the inferior medial region of the right
breast and highly suggestive of malignancy as BI-RADS
category 4. The left breast was categorized as BI-RADS
category 1 (Fig. 1). In mammary ultrasonography, an
extensive lesion of 12 × 24 × 17 mm was observed in the
right B region. The mass was lobular with a clear coarse
boundary. The internal echo was hypoechoic and het-
erogeneous (partial hemorrhage was suspected), and
the posterior echo was enhanced (Fig. 2a). The lesion
was hypervascular on color Doppler (data not shown).
In MRI of the mammary gland, a mass of 24 mm in
size was detected in the right B region. The time-
intensity curve was steep, and contrast enhancement
was observed from an early phase (Fig. 2b). Chest CT
showed an irregular tumor in the left upper lobe,
which was suspected to be lung cancer (Fig. 2c).
There was no liver metastasis. Bone scintigraphy
showed no abnormal accumulation suggesting
metastasis.
Histologic findings on needle biopsy specimens of the
lung tumor suggested that the lesion was poorly differ-
entiated carcinoma. Assuming that the tumor originated
from the lung, it was considered likely to be pleo-
morphic carcinoma. However, its histology was similar
to that in a biopsy specimen collected from the right
mammary gland (see below), indicating possible metas-
tasis of the mammary tumor.
Histologic findings on needle biopsy specimens of the
mammary tumor suggested that the lesion was assumed
to be carcinoma. Spindle cell carcinoma and metaplastic
carcinoma were possible, but the histology of the tumor
was similar to that observed in the left lung biopsy
specimen, suggesting that the lesion had the same origin
as that of the lung tumor.
In a preoperative histological examination after diagno-
sis, the histology of the tumors in the mammary gland
and lung were found to be similar, but there was a possi-
bility that the mammary tumor was spindle cell or meta-
plastic carcinoma, and the lesions were initially diagnosed
as double cancer of primary breast cancer and non-small
cell lung carcinoma (cT2N1M0 Stage IIA).
Surgery for the lung tumor of left upper lobectomy
and lymph node dissection was performed first. Histo-
logically, the lung tumor had dyscohesive proliferation of
spindle, oval, or polygonal cells and scattered multinu-
cleated giant cells (Fig. 3a). Immunohistochemically,
these tumor cells are partially positive for AE1/AE3
(Fig. 3b), and negative for TTF1 and ER (Fig. 3c). In
addition, the tumor had a few foci of squamous cell car-
cinoma. Furthermore, the patient had intrapulmonary
and lymph node metastasis. If the tumor originated from
the lung, these findings suggested pleomorphic carcin-
oma, but the histology was similar to that of the needle
biopsy specimen of the right mammary tumor; therefore,
Fig. 1 Mammography showing a shadow of an intense irregular mass in the inferior medial region of the right breast
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the possibility of breast cancer metastasis could not be
ruled out. Assuming primary lung cancer, the diagnosis
was LU, B1 + 2, 38 × 37 × 60 mm, pl0, D0, G4, Ly0, V1
(EVG), PLC (not tested), pm1, and pN2a-1(6/9).
After surgery for the lung tumor at 1 month after the
initial examination, surgery on the mammary gland was
performed. The white blood cell count was within the
normal range at the time of the first examination, but
markedly increased after the lung surgery and remained
at a high level. Preoperative chemotherapy was initially
planned for the mammary tumor, but surgical treatment
was selected based on the clinical course and histo-
pathological diagnosis. After surgery of right mastec-
tomy and full thickness skin graft, the mammary tumor
was diagnosed as right breast cancer (cT3N0M0, Stage
III). Axillary lymph node dissection was omitted.
The mammary lesion was thought to be a solid tumor
that was exposed to the skin. Histopathological findings
for the surgically excised mammary specimen are similar
to those of the lung tumor (Fig. 4a). However, a histo-
logic appearance of squamous cell carcinoma is not
identified. There were no typical features of conventional
breast cancer and ductal carcinoma in situ. Immunohis-
tochemically, mammary tumor cells are partially positive
for AE1/AE3 (Fig. 4b), and negative for ER (Fig. 4c),
PgR, HER2. Ki-67/MIB1 index of tumor cells are ≥90%.
In the course after mastectomy, lower abdominal dis-
tension occurred during the hospital stay. A 12-cm giant
mass was detected in the pelvis on imaging and diag-
nosed as a metastatic ovarian tumor. Bilateral pleural ef-
fusion, peritoneal dissemination, and findings suggesting
bone metastasis were also observed. Chemotherapy with
paclitaxel and carboplatin was performed about 1 month
after mastectomy, but the ovarian tumor size was not
reduced. Systemic conditions aggravated with disease
progression, and the treatment was discontinued after
the second cycle. The white blood cell count was abnor-
mally high during the course, then transiently decreased
after chemotherapy, but subsequently increased again
(Fig. 5). Palliative care was performed for disease aggra-
vation, but the patient died about 5 months after the
first examination (about 3 months after mastectomy).
Conclusions
Breast metastasis of cancer from organs other than the
mammary gland is rare, and accounts for only 0.5–2% of
all cases of malignant mammary gland tumors in
Western countries [2]. In Japan, only five cases of breast
metastasis of lung cancer have been reported [3–7],
including four cases of recurrence after surgery for
primary lung cancer [3, 5–7]. In the other case, metasta-
ses to the breast and multiple organs were observed in
the first examination [4]. There are no characteristic
imaging findings for differentiation of primary breast
Fig. 2 a On mammary ultrasonography, an extensive lobular lesion
of 12 × 24 × 17 mm with a clear coarse boundary was observed in the
right B/D region. b On mammary MRI, a contrast-enhanced mass was
observed from the early phase. c On chest CT, an irregular tumor that
was suspected to be lung cancer was present in the left upper lobe
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Fig. 3 Histology of the lung tumor. a Hematoxylin and eosin stain, ×200. Lung tumor of the present case exhibits dyscohesive growth of spindle,
oval, or polygonal tumor cells. Multinucleated giant cells are scattered. b AE1/AE3 immunohistochemistry, ×200. AE1/AE3-positive tumor cells are
scattered. c ER immunohistochemistry, ×200. There are no ER-positive tumor cells
Fig. 4 Histology of the breast tumor. a Hematoxylin and eosin stain, ×200. The histologic appearances of breast tumor are similar to those of the
lung tumor. b AE1/AE3 immunohistochemistry, ×200. AE1/AE3-positive tumor cells are scattered. c ER immunohistochemistry, ×200. There are no
ER-positive tumor cells
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cancer and breast metastasis, and thus histopathological
examination is useful for diagnosis.
The general features of breast metastasis of lung
cancer include (1) histology similar to that of the pri-
mary lesion, (2) infiltrative proliferation of cancer cells
around the duct and lobule of the mammary gland, and
(3) no cancer in the duct or lobule and retention of the
characteristic mammary gland structure [8]. The current
case has these three features.
A systematic review of 43 cases of breast metastasis
of lung cancer was published in 2014 [8]. These in-
cluded 33 cases of histologic type non-small cell car-
cinoma and 10 cases of small cell carcinoma. The
series included no case with metastasis of pleo-
morphic carcinoma. The mean age at the time of
diagnosis, ratio of males, and cigarette smoking rate
in non-small cell vs. small cell carcinoma cases show
no significant differences. Metastasis of non-small cell
carcinoma was metachronously discovered after treat-
ment such as surgery in 67% of cases, whereas the
metastatic lesion was discovered simultaneously at the
time of diagnosis in 80% of small cell carcinoma
cases.
Lung primary pleomorphic carcinoma is a rare tumor
that accounts for only about 0.3% of all lung cancer
cases [1]. The incidence is high in elderly men, and the
tumor has a causal relationship with cigarette smok-
ing [9]. The tumor is diagnosed after surgical resec-
tion in many cases due to the pathological
characteristics, but the treatment outcome and prog-
nosis are poor. The response of the tumor to chemo-
therapy is also low [10].
The patient in the current report was a female
cigarette smoker at high-risk of lung cancer, and lung
cancer and breast metastasis were observed at the first
examination. On imaging, there was no finding that
allowed differentiation from primary breast cancer, and
the histologic findings on needle biopsy specimens of
the lung and mammary gland specimens were also very
similar. Therefore, it was impossible to differentiate
whether the disease was double cancer (lung and breast
cancers), lung metastasis of breast cancer, or breast
metastasis of lung cancer until surgical resection of the
lung and mammary tumors.
Histologically, the lung tumor had dyscohesive pro-
liferation of spindle, oval, or polygonal cells and scat-
tered multinucleated giant cells. In addition, the tumor
had a few foci of squamous cell carcinoma. However, a
histologic appearance of squamous cell carcinoma is
not identified in the breast tumor. And there were no
typical features of conventional breast cancer and
ductal carcinoma in situ. We diagnosed this case the
breast metastasis of lung cancer, not primary breast
cancer.
In the review discussed above [8], it was stated that
when breast metastasis was simultaneously present
with lung cancer, the diagnosis could not be made be-
fore treatment, and the breast was surgically treated
at a high rate, as in the present case. Chemotherapy
is an option for so-called triple negative breast cancer,
but it cannot be performed without a reliable diag-
nostic basis. Sensitivity to chemotherapy was low in
our patient, and the disease rapidly progressed; thus,
malignancy was high and the prognosis was poor, as
in previous reports.
The white blood cell count in our patient was ab-
normally high during the disease course, and ultim-
ately elevated again following a transient decrease
Fig. 5 White blood cell counts over the disease course. The counts were abnormally high, corresponding to the disease state
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after chemotherapy. The serum G-CSF level was also
high, but G-CSF staining was negative on immuno-
histological examination. According to Asano et al. [11],
the diagnostic criteria for a G-CSF-producing tumor are
(1) an increase in peripheral blood white blood cells,
mainly mature neutrophils, (2) elevation of serum G-CSF,
(3) an increase in neutrophils in tumor-transplanted nude
mice, (4) reduction or disappearance of (1), (2), and (3) by
tumor excision or treatment, and (5) CSF activity in the
culture supernatant of tumor extract. Identification of
such tumors is simple based on the serum G-CSF activity
and immunostaining of tumor tissue with anti-G-CSF
antibody, but our case did not meet the definition of a
G-CSF-producing tumor.
In conclusion, this is the first report of breast metasta-
sis of pulmonary pleomorphic carcinoma. The disease
aggravated rapidly and differentiation of breast metasta-
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